Science
B.C. particle accelerator scores triumph with deal to produce ‘rarest drug on earth’ – q107.com
UBC’s TRIUMF facility is gearing up to produce actinium-225, a rare radioisotope that early research shows could have a powerful effect fighting cancer.
A team at the Canada’s particle accelerator facility at the University of British Columbia is celebrating a major triumph, inking a deal to produce a rare cancer drug that previously relied on nuclear waste.
The TRIUMF project has formed a partnership with Ontario-based Fusion Pharmaceuticals to upgrade its facility to produce actinium-225, nicknamed “the rarest drug on Earth.”
Read more: BWXT Peterborough touts ‘tremendous progress’ in medical isotope production at Darlington nuclear station
That…
-
Business5 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General8 hours agoAlbanese beats drum on economy as trade clouds gather
-
General7 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General5 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner